A detailed history of M&T Bank Corp transactions in Incyte Corp stock. As of the latest transaction made, M&T Bank Corp holds 11,037 shares of INCY stock, worth $651,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,037
Previous 11,687 5.56%
Holding current value
$651,403
Previous $733,000 14.32%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$56.55 - $66.59 $36,757 - $43,283
-650 Reduced 5.56%
11,037 $628,000
Q4 2023

Feb 06, 2024

SELL
$52.16 - $64.19 $7,615 - $9,371
-146 Reduced 1.23%
11,687 $733,000
Q3 2023

Nov 02, 2023

SELL
$57.77 - $65.93 $61,640 - $70,347
-1,067 Reduced 8.27%
11,833 $683,000
Q2 2023

Aug 09, 2023

SELL
$60.95 - $75.51 $67,349 - $83,438
-1,105 Reduced 7.89%
12,900 $803,000
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $26,968 - $33,027
384 Added 2.82%
14,005 $1.01 Million
Q4 2022

Feb 13, 2023

SELL
$67.18 - $84.11 $482,083 - $603,573
-7,176 Reduced 34.5%
13,621 $1.09 Million
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $460,451 - $576,489
6,854 Added 49.16%
20,797 $1.67 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $151,750 - $189,997
2,293 Added 19.68%
13,943 $732,000
Q2 2022

Aug 05, 2022

BUY
$66.18 - $83.18 $124,087 - $155,962
1,875 Added 19.18%
11,650 $817,000
Q1 2022

May 09, 2022

BUY
$66.02 - $79.71 $37,499 - $45,275
568 Added 6.17%
9,775 $776,000
Q4 2021

Feb 07, 2022

BUY
$63.34 - $74.11 $2,533 - $2,964
40 Added 0.44%
9,207 $675,000
Q3 2021

Oct 28, 2021

SELL
$68.67 - $84.02 $23,691 - $28,986
-345 Reduced 3.63%
9,167 $630,000
Q2 2021

Aug 13, 2021

SELL
$79.87 - $87.53 $11,740 - $12,866
-147 Reduced 1.52%
9,512 $800,000
Q1 2021

May 06, 2021

SELL
$76.02 - $100.5 $709,494 - $937,966
-9,333 Reduced 49.14%
9,659 $785,000
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $98,502 - $119,194
1,220 Added 6.86%
18,992 $1.65 Million
Q3 2020

Nov 06, 2020

BUY
$85.07 - $109.69 $50,191 - $64,717
590 Added 3.43%
17,772 $1.6 Million
Q2 2020

Jul 29, 2020

BUY
$74.18 - $108.93 $453,239 - $665,562
6,110 Added 55.18%
17,182 $1.79 Million
Q1 2020

May 14, 2020

SELL
$63.18 - $85.97 $3,853 - $5,244
-61 Reduced 0.55%
11,072 $811,000
Q4 2019

Feb 07, 2020

BUY
$73.04 - $95.72 $4,820 - $6,317
66 Added 0.6%
11,133 $973,000
Q3 2019

Nov 12, 2019

BUY
$72.82 - $86.52 $436 - $519
6 Added 0.05%
11,067 $822,000
Q2 2019

Aug 12, 2019

SELL
$73.52 - $88.7 $8,748 - $10,555
-119 Reduced 1.06%
11,061 $939,000
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $47,415 - $65,774
746 Added 7.15%
11,180 $962,000
Q4 2018

Feb 01, 2019

SELL
$58.5 - $69.94 $53,761 - $64,274
-919 Reduced 8.09%
10,434 $664,000
Q3 2018

Nov 09, 2018

BUY
$61.75 - $74.23 $53,166 - $63,912
861 Added 8.21%
11,353 $784,000
Q2 2018

Aug 10, 2018

SELL
$60.85 - $83.98 $536,697 - $740,703
-8,820 Reduced 45.67%
10,492 $702,000
Q1 2018

May 04, 2018

SELL
$83.06 - $100.98 $8,638 - $10,501
-104 Reduced 0.54%
19,312 $1.61 Million
Q4 2017

Feb 06, 2018

SELL
$93.56 - $116.6 $175,986 - $219,324
-1,881 Reduced 8.83%
19,416 $1.84 Million
Q3 2017

Nov 13, 2017

SELL
$109.15 - $138.27 $6,985 - $8,849
-64 Reduced 0.3%
21,297 $2.49 Million
Q2 2017

Aug 11, 2017

BUY
N/A
21,361
21,361 $2.69 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.